XHXuefei Han

Xuefei Han

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xuefei Han has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Descriptive epidemiology and prognostic factors of atypical teratoid/rhabdoid tumors in the United States, 2001–2021

    by Zhibin Li, Liyan Zhao, Hui Liu, Yao Zhao, Xuefei Han, Yubo Wang, Yunqian Li

    Atypical teratoid rhabdoid tumor (AT/RT) is a rare embryonal central nervous system tumor with a dismal prognosis that occurs mostly in early childhood. Since recent epidemiological and prognostic information is limited, we aimed to describe and analyze AT/RT-related incidences, temporal trends and prognostic factors. Incidence and survival data between 2001 and 2021 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Descriptive epidemiology was utilized to assess incidences and rate ratios. Temporal trends were assessed by Joinpoint analysis. Prognostic factors were evaluated by survival analysis. A total of 393 patients were included in our analysis. Most patients developed tumors at less than 1 year of age (33.6%). The overall incidence was 0.084 per 100,000 population. According to the SEER 17 data, AT/RT represented 18.3% of all CNS malignant tumors diagnosed in infants aged < 1 year, with a relatively high incidence of 0.583. The overall incidence trend increased nonsignificantly from 2004 to 2021 (P = 0.572). Older age, more aggressive tumor resection, radiotherapy and chemotherapy administration, and nonmetastasis status were related to improved overall survival (OS) and cancer-specific survival (CSS) via Kaplan-Meier analysis. Multivariable Cox regression analysis indicated that age, extent of resection, radiotherapy, chemotherapy and metastasis status were independent prognostic factors for OS and CSS. AT/RT, particularly in infants under 1 year of age, should receive increased attention from epidemiologists and clinicians. An aggressive multimodal regimen including surgery combined with chemotherapy and radiotherapy is necessary.


  • Open Access

    Radiation-Induced Cellular Senescence Reduces Susceptibility of Glioblastoma Cells to Oncolytic Vaccinia Virus

    by Quinn T. Storozynsky, Xuefei Han, Shae Komant, Kate C. Agopsowicz, Kyle G. Potts, Armin M. Gamper, Roseline Godbout, David H. Evans, Mary M. Hitt

    Glioblastoma (GBM) is a malignant brain cancer refractory to the current standard of care, prompting an extensive search for novel strategies to improve outcomes. One approach under investigation is oncolytic virus (OV) therapy in combination with radiotherapy. In addition to the direct cytocidal effects of radiotherapy, radiation induces cellular senescence in GBM cells. Senescent cells cease proliferation but remain viable and are implicated in promoting tumor progression. The interaction of viruses with senescent cells is nuanced; some viruses exploit the senescent state to their benefit, while others are hampered, indicating senescence-associated antiviral activity. It is unknown how radiation-induced cellular senescence may impact the oncolytic properties of OVs based on the vaccinia virus (VACV) that are used in combination with radiotherapy. To better understand this, we induced cellular senescence by treating GBM cells with radiation, and then evaluated the growth kinetics, infectivity, and cytotoxicity of an oncolytic VACV, ∆F4LΔJ2R, as well as wild-type VACV in irradiated senescence-enriched and non-irradiated human GBM cell lines. Our results show that both viruses display attenuated oncolytic activities in irradiated senescence-enriched GBM cell populations compared to non-irradiated controls. These findings indicate that radiation-induced cellular senescence is associated with antiviral activity and highlight important considerations for the combination of VACV-based oncolytic therapies with senescence-inducing agents such as radiotherapy.


  • Open Access

    NICD inhibits cell proliferation and promotes apoptosis and autophagy in PC12 cells

    by Bo Li, Ping Duan, Xuefei Han, Wenhai Yan, Ying Xing

    Pheochromocytoma is a tumor of the adrenal medulla for which surgical resection is the only therapy. Though the Notch1 signaling pathway has been suggested as a target for pheochromocytoma treatment, the effect of Notch1 intracellular domain (NICD) on pheochromocytoma cell growth remains unknown. In the present study, the effect of NICD on pheochromocytoma cell growth was examined, by use of a tetracycline‑inducible system for NICD overexpression in the PC12 pheochromocytoma cell line. Flow cytometry was used to determine the effect of NICD on cell cycle phase distribution and apoptosis in PC12 cells. Protein expression levels of microtubule associated protein 1 light chain 3 B (LC3B), Beclin 1, autophagy‑related (ATG) 5 and ATG7 were examined using western blot analysis. Untreated PC12 cells lack NICD expression, while treatment with doxycycline resulted in a significant NICD overexpression. NICD overexpression promoted cell apoptosis and suppressed cell proliferation via regulating S‑phase arrest. In addition, NICD overexpression stimulated the expression of autophagy‑related proteins LC3B, Beclin 1, ATG5 and ATG7. In conclusion, NICD promoted cell apoptosis, suppressed cell proliferation, and stimulated autophagy‑related protein expression in PC12 cells. The present data indicate that overexpression of NICD may be a promising potential therapy for pheochromocytoma.